Astellas Venture Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 94

  • Portfolio
  • 23

  • Exits
  • 49

Exits

Astellas Venture Management General Information

Description

Astellas Venture Management Founded in 1999, AVM is the corporate venture arm of Astellas Pharma and is headquartered in Brisbane, California. The firm makes investments in privately owned early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development.

Contact Information

Year Founded
2005
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 2000 Sierra Point Parkway
  • Suite 500
  • Brisbane, CA 94005
  • United States
+1 (650) 000-0000

Astellas Venture Management Investments & Acquisitions (94)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Casma Therapeutics 07-Jul-2022 Later Stage VC 0000 Drug Discovery Generating Revenue 000000000 000000 00.0
000 000000000 23-Jun-2022 00000 00000 0000 Biotechnology Generating Revenue 000000000 000000 00.0
000000 00000000000 21-Jun-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000000 000000 00.0
0000 0000000000000 11-Apr-2022 00000 00000 Drug Discovery Clinical Trials - General 000000000 000000
0000000 000000000 07-Mar-2022 00000 00000 00.00 Drug Discovery Generating Revenue 000000000 000000
00000000 10-Nov-2021 00000 00000 0000 Drug Discovery Product Development 000000000 000000 00.0
0000000 04-May-2021 00000 00000 0000 Drug Discovery Generating Revenue 000000000 000000
000000000 23-Mar-2021 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue 000000000 000000 00.0
Orna Therapeutics 24-Feb-2021 Early Stage VC 0000 Drug Delivery Product Development 000000000 000000
Catamaran Bio 23-Nov-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 000000 00000 00.0
You’re viewing 10 of 94 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astellas Venture Management Exits (49)

Company Name Exit Date Exit Type Exit Size
Seldar Pharma 01-Jun-2022 Secondary Transaction - Private
000000 00000000000 10-Jan-2022 000 00 00000000
00000000 000000000 26-Aug-2021 0000000 000000 00000
00000 000000000000 16-Jul-2021 000 00000
000000 000000 01-May-2021 000000000 00000000
000000 00000000000 24-Feb-2021 000 00 00000000
0000000 12-Feb-2021 000000 0000000000 0000
00000000 000000 05-Oct-2020 000 00 00000000
Oncorus 02-Oct-2020 IPO 0000
Innocrin Pharmaceuticals 01-Oct-2019 Out of Business
You’re viewing 10 of 49 exits. Get the full list »

Astellas Venture Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Astellas Venture Management Team (24)

Name Title Deals Funds Boards Office
William Watt Ph.D President 0 Brisbane, CA
Hiromichi Kimura Ph.D Investment Director 0 0 0 Brisbane, CA
Satoshi Konagai Senior Investment Manager Brisbane, CA
Tadayoshi Hirata Senior Investment Manager 0 0 Brisbane, CA
Nagisa Sakurai Ph.D Senior Investment Manager Brisbane, CA
You’re viewing 5 of 24 team members. Get the full list »

Astellas Venture Management Co-Investors (115)

Name With Exits Lead Partner Series Industry
MPM Capital 5 0 Series chart Industry bar
Longwood Fund 0 0 Series chart Industry bar
Novartis Venture Fund 0 0 0 Series chart Industry bar
Osage University Partners 0 0 0 Series chart Industry bar
Parkwalk Advisors 0 0 Series chart Industry bar
You’re viewing 5 of 115 co-investors. Get the full list »